Interestingly, TCGA patient data analysis also showed that EIF4A2 expression was prognostic of poor prognosis in liver cancer, head and neck cancer, melanoma and prostate cancer (Additional file 1: Figure S1F-G). The gene discussed is EIF4A2; the disease is melanoma.